Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Institute of Pathology and Southwest Cancer Center, Key Laboratory of the Ministry of Education, Southwest Hospital, Army Medical University, Chongqing, China.
Front Endocrinol (Lausanne). 2021 Sep 9;12:712513. doi: 10.3389/fendo.2021.712513. eCollection 2021.
The improvement in the quality of life is accompanied by an accelerated pace of living and increased work-related pressures. Recent decades has seen an increase in the proportion of obese patients, as well as an increase in the prevalence of breast cancer. More and more evidences prove that obesity may be one of a prognostic impact factor in patients with breast cancer. Obesity presents unique diagnostic and therapeutic challenges in the population of breast cancer patients. Therefore, it is essential to have a better understanding of the relationship between obesity and breast cancer. This study aims to construct a prognostic risk prediction model combining obesity and breast cancer. In this study, we obtained a breast cancer sample dataset from the GEO database containing obesity data [determined by the body mass index (BMI)]. A total of 1174 genes that were differentially expressed between breast cancer samples of patients with and without obesity were screened by the rank-sum test. After weighted gene co-expression network analysis (WGCNA), 791 related genes were further screened. Relying on single-factor COX regression analysis to screen the candidate genes to 30, these 30 genes and another set of TCGA data were intersected to obtain 24 common genes. Finally, lasso regression analysis was performed on 24 genes, and a breast cancer prognostic risk prediction model containing 6 related genes was obtained. The model was also found to be related to the infiltration of immune cells. This study provides a new and accurate prognostic model for predicting the survival of breast cancer patients with obesity.
生活质量的提高伴随着生活节奏的加快和工作压力的增加。近几十年来,肥胖患者的比例有所增加,乳腺癌的发病率也有所上升。越来越多的证据表明,肥胖可能是乳腺癌患者预后的影响因素之一。肥胖症在乳腺癌患者人群中存在独特的诊断和治疗挑战。因此,更好地了解肥胖症和乳腺癌之间的关系至关重要。本研究旨在构建一个结合肥胖症和乳腺癌的预后风险预测模型。
在这项研究中,我们从 GEO 数据库中获得了一个包含肥胖数据[由体重指数 (BMI) 确定]的乳腺癌样本数据集。通过秩和检验筛选出了 1174 个在肥胖和非肥胖乳腺癌患者样本之间差异表达的基因。经过加权基因共表达网络分析 (WGCNA),进一步筛选出 791 个相关基因。依赖单因素 COX 回归分析筛选候选基因至 30 个,这 30 个基因与另一组 TCGA 数据相交,得到 24 个共同基因。最后,对 24 个基因进行lasso 回归分析,得到了一个包含 6 个相关基因的乳腺癌预后风险预测模型。该模型还与免疫细胞浸润有关。
这项研究为预测肥胖乳腺癌患者的生存提供了一个新的、准确的预后模型。